NQO1
MOLECULAR TARGETNAD(P)H quinone dehydrogenase 1
NQO1 (NAD(P)H quinone dehydrogenase 1) is targeted by 6 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting NQO1
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | lapachone | 4.34 | 76 |
| 2 | dicumarol | 3.56 | 34 |
| 3 | bisantrene | 2.77 | 15 |
| 4 | alyssin [Supplementary Concept] | 2.30 | 9 |
| 5 | Vitamin K 3 | 1.39 | 3 |
| 6 | Hydrogen Peroxide | 0.69 | 1 |
About NQO1 as a Drug Target
NQO1 (NAD(P)H quinone dehydrogenase 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 6 compounds with documented NQO1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
NQO1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.